Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
SPRY
— ARS Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
AUG 13, 2026
REVENUE
$33.7M
+48.4%
NET MARGIN
-185.2%
+82.1 PTS
EPS
-$0.63
-3.3%
FREE CASH FLOW
-$60.9M
-35.6%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 4
OLDER CALL →